Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery

NCT05950152 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Post-operative

Interventions

DRUG: Meloxicam Injection 30mg
DRUG: Meloxicam Injection 60mg
DRUG: Nacl 0.9%

Sponsor

Beijing Tide Pharmaceutical Co., Ltd

Collaborators

[object Object]